SymbioCellTech Revenue and Competitors
Estimated Revenue & Valuation
- SymbioCellTech's estimated annual revenue is currently $1.1M per year.
- SymbioCellTech's estimated revenue per employee is $155,000
Employee Data
- SymbioCellTech has 7 Employees.
- SymbioCellTech grew their employee count by 40% last year.
SymbioCellTech's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO, President and Founder SymbioCellTech, LLC | Reveal Email/Phone |
2 | Founder & CEO | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Chief Operating Officer | Reveal Email/Phone |
5 | Scientist | Reveal Email/Phone |
SymbioCellTech Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.8M | 5 | 0% | N/A | N/A |
#2 | $2.8M | 18 | 64% | $25.1M | N/A |
#3 | $1.4M | 9 | 0% | N/A | N/A |
#4 | $7.1M | 46 | 39% | N/A | N/A |
#5 | $1.4M | 9 | -50% | N/A | N/A |
#6 | $1.4M | 9 | -10% | N/A | N/A |
#7 | $25.9M | 167 | 11% | N/A | N/A |
#8 | $1.6M | 40 | -48% | $17.8M | N/A |
#9 | $3.4M | 22 | 83% | N/A | N/A |
#10 | $2M | 13 | 0% | N/A | N/A |
What Is SymbioCellTech?
SymbioCellTech (SCT) is an early stage, university spin out, that has developed stem cell-based technology that achieves euglycemia (glucose control) in Type-1 Diabetes, and will soon be adapted for Type-2 Diabetes. The SCT proprietary Neo-Iset therapy, comprising both pancreatic islet and mesenchymal stem cells, can be administered in a simple out-patient procedure resulting in glucose control identical to that of a normal healthy individual. Backed by rigorous NIH, VA and privately funded research and resultant data, SCT has completed pre-clinical trials and is preparing for FDA submission and approval to begin well-designed, controlled, clinical trials treating humans suffering from Type-1 Diabetes. FDA Investigational New Animal Drug (INAD) approval for diabetic companion animals has been approved and canine clinical trials are ongoing with outstanding results and outcomes.
keywords:N/AN/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
40%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.1M | 7 | 17% | N/A |
#2 | $0.5M | 7 | -22% | N/A |
#3 | $0.5M | 7 | N/A | N/A |
#4 | $0.5M | 7 | 17% | N/A |
#5 | $1.1M | 7 | 0% | N/A |